Completeness of Reporting of Patient-Relevant Clinical Trial Outcomes: Comparison of Unpublished Clinical Study Reports with Publicly Available Data
PLoS MedicinePublished 8 October 2013Open access
Beate Wieseler, Natalia Wolfram, Natalie McGauran, Michaela Florina Kerekes, Volker Vervölgyi, Petra Kohlepp
Citations128
SJR quartileQ1
SJR score4.28
SNIP3.21
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Beate Wieseler and colleagues compare the completeness of reporting of patient-relevant clinical trial outcomes between clinical study reports and publicly available data.
Abstract
In contrast to CSRs, publicly available sources provide insufficient information on patient-relevant outcomes of clinical trials. CSRs should therefore be made publicly available. Please see later in the article for the Editors' Summary.
Keywords
Decision SciencesMedicinePharmacology, Toxicology and Pharmaceutics
BMC MedicineCONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
13,537 Citations2010the CONSORT Group, Kenneth F. Schulz +2 more
Annals of Internal MedicineCONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
3,864 Citations2010Kenneth F. Schulz, Douglas G. Altman +2 more
The latest version of the CONSORT statement, CONSORT 2010, is described, which updates the reporting guideline based on new methodological evidence and accumulating experience.
Elsevier eBooksInternational Conference on Harmonisation
1,480 Citations2014R.C. Guy
The goal of the ICH is to achieve greater harmonization in the interpretation and application of technical guidelines and requirements for product registration, thereby reducing duplication of testing and reporting carried out during the research and development of new medicines.
New England Journal of MedicineClinical Trial Registration: A Statement from the International Committee of Medical Journal Editors
1,211 Citations2004Catherine De Angelis, Jeffrey M. Drazen +11 more
Health Technology AssessmentDissemination and publication of research findings: an updated review of related biases
1,030 Citations2010Fujian Song, Susan Parekh +8 more
There was convincing evidence that outcome reporting bias exists and has an impact on the pooled summary in systematic reviews, and empirical evidence suggests that published studies tended to report a greater treatment effect than those from the grey literature.
JAMAComparison of Registered and Published Primary Outcomes in Randomized Controlled Trials
746 Citations2009Sylvain Mathieu
Comparison of the primary outcomes of RCTs registered with their subsequent publication indicated that selective outcome reporting is prevalent.
BMJReboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials
575 Citations2010Dirk Eyding, M. Lelgemann +7 more
Reboxetine is, overall, an ineffective and potentially harmful antidepressant and Published evidence is affected by publication bias, underlining the urgent need for mandatory publication of trial data.
TrialsReporting bias in medical research - a narrative review
455 Citations2010Natalie McGauran, Beate Wieseler +4 more
New England Journal of MedicineOutcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use
362 Citations2009S. Swaroop Vedula, Lisa Bero +2 more
Examination of reporting practices for trials of gabapentin funded by Pfizer and Warner-Lambert's subsidiary, Parke-Davis for off-label indications found selective outcome reporting threatens the validity of evidence for the effectiveness of off- label interventions.
BMJCompliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study
295 Citations2012Andrew Prayle, Matthew Hurley +1 more
Examination of compliance with mandatory reporting of summary clinical trial results on ClinicalTrials.gov found most trials subject to mandatory reporting did not report results within a year of completion.
PLoS MedicineThe Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience
164 Citations2012Peter Doshi, Tom Jefferson +1 more
Peter Doshi and colleagues describe their experience trying and failing to access clinical study reports from the manufacturer of Tamiflu and challenge industry to defend their current position of RCT data secrecy.
BMJImpact of document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications
129 Citations2012Beate Wieseler, M Kerekeş +3 more
PLoS ONECompleteness and Changes in Registered Data and Reporting Bias of Randomized Controlled Trials in ICMJE Journals after Trial Registration Policy
119 Citations2011Mirjana Huić, Matko Marušić +1 more
The adequacy of randomized controlled trial (RCT) registration, changes to registration data and reporting completeness for articles in ICMJE journals during 2.5 years after registration requirement policy was assessed.
PLoS MedicineOpen Clinical Trial Data for All? A View from Regulators
107 Citations2012Hans‐Georg Eichler, Éric Abadie +3 more
Hans-Georg Eichler from the European Medicines Agency and colleagues provide a view from regulators on access to clinical trial data.
BMJOpening up data at the European Medicines Agency
105 Citations2011Peter C Gøtzsche, Andreas Jørgensen
Peter Gøtzsche and Anders Jørgensen describe their efforts to get access to unpublished trial reports from the European Medicines Agency.
BMJNeuraminidase inhibitors--the story behind the Cochrane review
87 Citations2009Peter Doshi
Although billions have been spent on oseltamivir in the face of pandemic influenza, the team updating the Cochrane review of neuraminidase inhibitors in healthy adults found that the public evidence base for this global public health drug was fragmented and inconsistent.
PLoS MedicineDifferences in Reporting of Analyses in Internal Company Documents Versus Published Trial Reports: Comparisons in Industry-Sponsored Trials in Off-Label Uses of Gabapentin
87 Citations2013S. Swaroop Vedula, Tianjing Li +1 more
BMJ OpenClinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reports
77 Citations2013Peter Doshi, Tom Jefferson
Clinical study reports represent a hitherto mostly hidden and untapped source of detailed and exhaustive data on each trial and should form the basic unit for evidence synthesis as their use is likely to minimise the problem of reporting bias.
Annals of Internal MedicineComparative Effectiveness Research: A Progress Report
75 Citations2010Harold C. Sox
This progress report summarizes how the recipients of the funds-the National Institutes of Health, Agency for Healthcare Research and Quality, and Office of the Secretary of the U.S. Department of Health and Human Services-are spending the $1.1 billion, how the Institute of Medicine priority topics have fared in the agencies' funding programs, and the developing plans for a national CER program.
BMJFinding studies on reboxetine: a tale of hide and seek
36 Citations2010Beate Wieseler, Natalie McGauran +1 more
The experience with the assessment of reboxetine is used to illustrate how publication bias affects health policy decisions and offer some solutions.
TrialsComparative effectiveness research: Challenges for medical journals
34 Citations2010Harold C. Sox, Mark Helfand +6 more
This editorial lays out principles for journals considering publication of Comparative Effectiveness Research (CER) and will be also published in Medical Decision Making, Croatian Medical Journal, The Cochrane Library, Trials, and Journal of Clinical Epidemiology.
BMJ OpenDo urology journals enforce trial registration? A cross-sectional study of published trials
33 Citations2011Frank Kunath, Henrik R. Grobe +5 more
The existence of a statement about trial registration in author instructions resulted in a higher proportion of registered RCTs in those journals, and Journals with higher IFs were more likely to mention trial registration.
ScienceClosing a Loophole in the FDA Amendments Act
15 Citations2008Erick H. Turner, Norwan J. Moaleji +1 more
PLoS MedicineComparative Effectiveness Research: Challenges for Medical Journals
14 Citations2010Harold C. Sox, Mark Helfand +6 more
Drawing on many years of collective experience in assessing these issues in the course of evaluating health research through peer review, the present Editorial supports the following principles and standards for CER.
Medical Decision MakingComparative Effectiveness Research: Challenges for Medical Journals
13 Citations2010Harold C. Sox, Mark Helfand +5 more
This editorial lays out principles for journals considering publication of Comparative Effectiveness Research (CER) and will be also published in Medical Decision Making, Croatian Medical Journal, The Cochrane Library, Trials, and Journal of Clinical Epidemiology.
PLoS MedicineGetting More Generous with the Truth: Clinical Trial Reporting in 2013 and Beyond
7 Citations2013The PLOS Medicine Editors
The PLOS Medicine editors discuss the recent initiative from the European Medicines Agency to commit to releasing clinical-trial data and how important such moves are for rebuilding trust between the pharmaceutical companies and society.
BMJEuropean commission proposes new laws to halt decline in number of clinical trials
4 Citations2012R. Watson
New legislation will replace rules that have been in place since 2001 and aims to encourage the development of new treatments and remove some of the regulatory burdens on clinical trials in the European Union.